TSC2/PKD1 Contiguous Gene Deletion Syndrome: A Case Series
Eduardo de Oliveira Valle1, Mateus Coelho Guerreiro1, Jose Otto Reusing2
1Division of Nephrology, School of Medicine, University of São Paulo, São Paulo, Brazil; Division of Molecular Medicine, School of Medicine, University of São Paulo, São Paulo, Brazil.
TSC2/PKD1 contiguous gene deletion syndrome (CGS) shows a variable clinical course, with some patients reaching end-stage kidney disease (ESKD) later than previously thought. This genetic disorder can present with kidney phenotypes similar to severe autosomal dominant polycystic kidney disease (ADPKD).
Area of Science:
- Genetics and rare diseases
- Nephrology and kidney disease progression
Background:
- TSC2/PKD1 contiguous gene deletion syndrome (CGS) is characterized by features of tuberous sclerosis complex (TSC) and autosomal dominant polycystic kidney disease (ADPKD).
- CGS has been historically associated with a severe kidney phenotype, including childhood-onset end-stage kidney disease (ESKD) within three decades.
- Recent reports suggest a more variable clinical course for CGS, necessitating further characterization.
Purpose of the Study:
- To characterize the clinical spectrum and natural history of TSC2/PKD1 contiguous gene deletion syndrome (CGS).
- To investigate the variability in kidney survival and ESKD progression among CGS patients.
- To compare the kidney phenotype of CGS with severe autosomal dominant polycystic kidney disease (ADPKD).
Main Methods:
- A case series study design was employed.
- Eleven patients and one unaffected individual from two CGS pedigrees were analyzed.
- Clinical data and kidney survival were retrospectively evaluated.
Main Results:
- Patients with CGS exhibited widely variable kidney survival, with some reaching the fourth decade without ESKD, even without mosaicism.
- The median age of ESKD onset was 22.5 years, while individuals not developing ESKD had a median age of 25.5 years.
- The clinical course and age of ESKD onset in CGS patients showed significant variability, overlapping with severe ADPKD phenotypes.
Conclusions:
- Patients with CGS have a more variable clinical course than previously reported, with potential for later ESKD onset, irrespective of mosaicism.
- The kidney phenotype in CGS can range from severe progression to a course resembling severe ADPKD.
- CGS should be considered in patients with severe ADPKD lacking TSC manifestations and in TSC patients with rapidly progressing cystic kidney disease.
Related Concept Videos
Karyotyping
Sex-linked Disorders
Karyotyping
Incomplete Dominance
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


